Previous close | 8.00 |
Open | 8.00 |
Bid | 13.00 |
Ask | 17.90 |
Strike | 75.00 |
Expiry date | 2023-04-21 |
Day's range | 8.00 - 8.00 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Bicycle (BCYC) and Novartis enter into a collaboration agreement to develop, manufacture and commercialize conjugate drugs for several oncology indications. Stock soars following the news.
Novartis (NVS) Kisqali meets primary endpoint of invasive disease-free survival in certain patients with early breast cancer at risk of recurrence.